The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Drug effects on the thyroid.
Abstract
The list of medications, many commonly used, that adversely affect thyroid function or the interpretation of standard thyroid tests is growing. This review addresses drug-induced thyroid dysfunction, emphasizing clinically relevant interactions and laboratory assay artifacts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-induced hypothyroidism is caused by medications such as amiodarone, lithium, and immune checkpoint inhibitors ( Figure 1 ). 28,29”
From Hypothyroidism: A Review (2025) · cites this paper as [28]
In the citing paper
“while biotin may interfere with some T4 assay systems (79, 80).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“A number of drugs, such as phenytoin, carbamazepine, salsalate, salicylate, furosemide, diclofenac, ethacrynic acid, and heparin, have been observed in vitro to displace T4 from the distribution proteins, changing the amount of thyroxine bound to plasma protein”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“Some of these drugs may also directly interfere with components and principles used for the hormone assays.136”
In the citing paper
“A number of medications can affect the thyroid function tests not only by interfering with the synthesis, transport, and metabolism of TSH and thyroid hormones but also by interfering with thyroid function immunoassays (30, 37–40) ( Table 1 ).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [37]
In the citing paper
“On the other hand, retinoids, mitotane and several drugs modulating the immune system and used for antineoplastic purpose may result in hypophysitis and cause clinically significant central hypothyroidism (Burch, 2019;Feldt-Rasmussen and Klose 2020;Feldt-Rasmussen and Rasmussen, 2018), as may head trauma including those related to sport and blast injuries (Benvenga et al., 2018).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“Fortunately, most of these medications do not cause clinically evident central hypothyroidism.”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“A number of other medications and drugs of abuse reportedly increase TBG levels: selective oestrogen receptor modulators, tamoxifen, heroin, methadone, 5-fluorouracil, and mitotane [ 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Firstly, therapeutic levels of phenytoin, carbamazepine, salsalate, salicylate, furosemide, fenclofenac, ethacrynic acid, and heparin induce the displacement of T4 from the binding proteins in vitro [ 87 , 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Conversely, exposure to glucocorticoids, niacin, and androgens leads to a fall in TBG levels and thus a decrease in the LT4 requirement [ 88 , 92 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
Citations
Cites
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S. M., Négrier, S., Szczylik, C. A., Пили, Р., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,182
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D. F., Reeves, J. A., Hawkins, R. E., Guo, J., Nathan, P., Staehler, M. D., SOUZA, P. D., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,928
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Barroso-Sousa, R., Barry, W. T., Garrido-Castro, A. C., Hodi, F. S., Min, L., Krop, I. E., & Tolaney, S. M. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3064 · Cited by 1,115
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 881
Bertrand, A., Kostine, M., Barnetche, T., Truchetet, M.-E., & Schaeverbeke, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0455-8 · Cited by 704
Research works printed but not linked: 4
- Kopp P, 2013, In: Braverman LE, Cooper DS, eds. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 10th ed, 48
- Duvic M, 2001, Arch Dermatol, 137, 581
- Martino E, 2001, Endocr Rev, 22, 240
- 10.1001/jama.1996.03530430039036 · DOI · Paper page
Cited by
Sorted by citations
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
Saevarsdottir, S., Olafsdottir, T. A., Ivarsdottir, E. V., Halldorsson, G. H., Gunnarsdottir, K., Sigurdsson, A., Johannesson, A., Sigurdsson, J. K., Juliusdottir, T., Lund, S. H., et al. (2020) · Nature · doi:10.1038/s41586-020-2436-0 · Cited by 137
Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside
Yamakawa, H., Kato, T., Noh, J. Y., Yuasa, S., Kawamura, A., Fukuda, K., & Aizawa, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.606931 · Cited by 137
Euthyroid Sick Syndrome in Patients With COVID-19
Zou, R., Wu, C., Zhang, S., Wang, G., Zhang, Q., Yu, B., Wu, Y., Dong, H., Wu, G., Wu, S., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.566439 · Cited by 117
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 129
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
“Some of these drugs may also directly interfere with components and principles used for the hormone assays.(136) Rarely, more extreme analytical errors are present(137) (Table 5).”
BackgroundThe cytokine storm and thyroid hormone changes in COVID-19
Croce, L., Gangemi, D., Ancona, G., Liboà, F., Bendotti, G., Minelli, L., & Chiovato, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01506-7 · Cited by 103
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 108
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
McDermott, M. T. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202007070 · Cited by 84
Scappaticcio, L., Trimboli, P., Keller, F., Imperiali, M., Piccardo, A., & Giovanella, L. (2019) · Clinical Endocrinology · doi:10.1111/cen.14130 · Cited by 76
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay
Conigliaro, P., D’Antonio, A., Pinto, S., Chimenti, M. S., Triggianese, P., Rotondi, M., & Perricone, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102529 · Cited by 71
Ovčariček, P. P., Görges, R., & Giovanella, L. (2023) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2023.11.002 · Cited by 85
Levothyroxine therapy in elderly patients with hypothyroidism
Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641560 · Cited by 60
Chaker, L., & Papaleontiou, M. (2025) · JAMA · doi:10.1001/jama.2025.13559 · Cited by 63
Caron, P., Grunenwald, S., Persani, L., Borson-Chazot, F., Leroy, R., & Duntas, L. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09691-9 · Cited by 53
Ruggeri, R. M., Giovanellla, L., & Campennì, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01863-x · Cited by 41
Caye, A., Pilz, L. K., Maia, A. L., Hidalgo, M. P. L., Furukawa, T. A., & Kieling, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.011 · Cited by 38
McDermott, M. T. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202004070 · Cited by 35
Centanni, M., Duntas, L., Feldt-Rasmussen, U., Koehrle, J., Peeters, R. P., Razvi, S., Trimboli, P., & Virili, C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0123 · Cited by 38
“…phenytoin, carbamazepine, salsalate, salicylate, furosemide, diclofenac, ethacrynic acid, and heparin, have been observed in vitro to displace T4 from the distribution proteins, changing the amount of thyroxine bound to plasma protein, while biotin may interfere with some T4 assay systems (79, 80).”
Laboratory Thyroid Tests: A Historical Perspective
Spencer, C. A. (2023) · Thyroid · doi:10.1089/thy.2022.0397 · Cited by 34
Thyroid disease and covid‐19 infection: Case series
Allam, M. M., El‐Zawawy, H. T., Ahmed, S. M., & Abdelhamid, M. A. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4225 · Cited by 33
Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)
Halsall, D. J., & Oddy, S. (2021) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563220969150 · Cited by 28
A Scoping Review on the Prevalence of Hashimoto’s Thyroiditis and the Possible Associated Factors
Vargas‐Uricoechea, H., Castellanos-Pinedo, A., Urrego-Noguera, K., Fernández, M. V. P., Meza-Cabrera, I. A., & Vargas-Sierra, H. D. (2025) · Medical Sciences · doi:10.3390/medsci13020043 · Cited by 35
Isolated anterior pituitary dysfunction in adulthood
Prencipe, N., Marinelli, L., Varaldo, E., Cuboni, D., Berton, A. M., Bioletto, F., Bona, C., Gasco, V., & Grottoli, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1100007 · Cited by 28
Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection
Vassiliadi, D. A., Ilias, Ι., Pratikaki, M. E., Jahaj, E., Vassiliou, A. G., Detsika, M. G., Ampelakiotou, K., Koulenti, M., Manolopoulos, K. N., Tsipilis, S., et al. (2021) · Endocrine Connections · doi:10.1530/ec-21-0029 · Cited by 27
Croce, L., de Martinis, L., Pinto, S., Coperchini, F., Dito, G., Bendotti, G., Pasquali, D., Cappelli, C., Latrofa, F., Magri, F., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01249-x · Cited by 27
Shockley, K. R., Cora, M. C., Malarkey, D. E., Jackson‐Humbles, D. N., Vallant, M. K., Collins, B., Mutlu, E., Robinson, V. G., Waidyanatha, S., Zmarowski, A., et al. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.07.016 · Cited by 25
Huang, K. J., Zhou, W., Fu, J., Zhang, Q., Teng, Y., Gu, L., Fu, Y., Hu, B., Mei, Y., Zhang, H., et al. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c01094 · Cited by 23
Gigliotti, B. J., & Jasim, S. (2023) · Endocrine · doi:10.1007/s12020-023-03548-8 · Cited by 21
Zhao, Y. Y., Wen, S. W., Li, M., Sun, Z., Yuan, X., Retnakaran, R. R., Zhang, R., & Zhai, D. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14928 · Cited by 18
Diabetes insipidus secondary to nivolumab-induced neurohypophysitis and pituitary metastasis
Fosci, M., Pigliaru, F., Salcuni, A. S., Ghiani, M., Cherchi, M. V., Calia, M., Loviselli, A., & Velluzzi, F. (2021) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-20-0123 · Cited by 17
Cardiac manifestations in hyperthyroidism
Navarro, A., Cruz-Cuevas, J. D., Ordoñez, N. A., Giral, H., Palmezano, J., Bolívar-Mejía, A., Santana, Q., Fernandez, R., Durango, L. F., Saldarriaga, C., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304136 · Cited by 18
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15
“Dietary soya, as well as calcium, iron or iodide supplements may reduce the absorption of LT4 into the circulation [69-71].”
BackgroundAmiodarone-induced thyrotoxicosis
Schubert, L., Bricaire, L., & Groussin, L. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.04.009 · Cited by 15
Wang, Y., Liu, Y., Chen, L., Chen, Z., Wang, X., Jiang, R., Zhao, K., & He, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.595355 · Cited by 15
Thyroid Emergencies: A Narrative Review
Kruithoff, M., & Gigliotti, B. J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.010 · Cited by 17
Saevarsdóttir, S., Bjarnadóttir, K., Markusson, T., Berglund, J., Olafsdottir, T. A., Halldorsson, G. H., Rutsdottir, G., Gunnarsdóttir, K., Arnthorsson, A. O., Lund, S. H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50007-7 · Cited by 15
Gietka-Czernel, M., Hubalewska-Dydejczyk, A., Kos-Kudła, B., Lewiński, A., Ruchała, M., Syrenicz, A., & Zgliczyński, W. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0065 · Cited by 13
Percik, R., Liel, Y., Urban, D., Bar, J., Ben‐Ami, E., & Tailakh, M. A. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1958006 · Cited by 13
Hypothyroidism, comorbidity and health-related quality of life: a population-based study
Wouters, H. J. C. M., Wolffenbuttel, B. H. R., Kobold, A. C. M., Links, T. P., Huls, G. A., & van der Klauw, M. M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0266 · Cited by 12
Keen, F., Chalishazar, A., Mitchem, K., Dodd, A., & Kalhan, A. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0119 · Cited by 12
Approach to the Patient With a Suppressed TSH
Praw, S. S., & Brent, G. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac635 · Cited by 13
Voll, M., Øystese, K. A., Høiskar, E., Johansen, O., Nyvold, C., Norheim, I., von Lueder, T. G., & Andersen, G. Ø. (2021) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytab017 · Cited by 11
Concurrent Use of Thyroid Hormone Therapy and Interfering Medications in Older US Veterans
Livecchi, R., Coe, A. B., Reyes-Gastelum, D., Banerjee, M., Haymart, M. R., & Papaleontiou, M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac216 · Cited by 10
Vasiljev, V., Subotić, A., Juraga, D., Bilajac, L., Jelaković, B., & Rukavina, T. (2022) · Southeastern European medical journal · doi:10.26332/seemedj.v6i1.241 · Cited by 10
Deligiorgi, M. V., & Trafalis, D. T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123417 · Cited by 12
Gorini, F., & Vassalle, C. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032389 · Cited by 10
Phan, G. Q., Yavuz, S., Stamatouli, A. M., Madan, R., Chen, S., Grover, A. C., Nilubol, N., Bedoya, P., Trankle, C. R., Markley, R., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1522753 · Cited by 9
Considerations in the Diagnosis and Management of Thyroid Dysfunction in Older Adults
Jasim, S., & Papaleontiou, M. (2025) · Thyroid · doi:10.1089/thy.2025.0128 · Cited by 13
Therapie mit Schilddrüsenhormonen im Alter
Iwen, K. A., & Brabant, G. E. (2020) · Der Internist · doi:10.1007/s00108-020-00790-4 · Cited by 10
Zhan, L., Yin, H., Gao, Y., Li, Y., & Ma, J. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s435138 · Cited by 9
Cao, J., Zhao, S., Zhang, Y., Cai, J., Zhang, L., & Yang, L. (2024) · Animal Bioscience · doi:10.5713/ab.23.0508 · Cited by 7
Nephrotic Syndrome as a Cause of Transient Clinical Hypothyroidism
Silva, V. B., Pereira, M. T., Moreira, C. L., Monteiro, S. S., Inácio, I. M. R., & Cardoso, H. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/5523929 · Cited by 7
A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility
Carafone, L. E., Knutson, A. J., & Gigliotti, B. J. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1795160 · Cited by 10
Drug-induced hypothyroidism in tuberculosis
Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Osorio, E. R. G., Urteaga, L. A. C., Pecho‐Silva, S., Rodríguez-Hidalgo, L. A., & Concepción‐Zavaleta, M. J. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2307525 · Cited by 6
Keen, F., Williams, D. M., Essame, J., Udiawar, M., Nagarajah, K., Witczak, J., Mitchem, K. L., & Kalhan, A. (2023) · Clinical Endocrinology · doi:10.1111/cen.14977 · Cited by 5
Zhao, Y. Y., Wang, N., Wen, S. W., Li, M., Yuan, Y., Retnakaran, R. R., Hao, W., Zhang, R., & Zhai, D. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14949 · Cited by 6
Abualia, M., Amarin, J. Z., & Zayed, A. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1912672 · Cited by 6
Ngan, T. T., Tra, D. H., Mai, N. T. Q., Dung, H. V., Khai, N. V., Linh, P. V., & Phương, N. T. T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1415206 · Cited by 6
Engaging Pathology Residents in Clinical Chemistry: The Essential Ingredient Is a Committed Teacher
Singh, G., Bollag, R. J., & Savage, N. M. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa140 · Cited by 5
Zhai, D., Chen, J., Guo, B., Retnakaran, R. R., Gao, S., Zhang, X., Hao, W., Zhang, R., Zhao, Y. Y., & Wen, S. W. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15163 · Cited by 5
Zhao, Y. Y., Guan, Q., Shi, J., Sun, J., Wang, Q., Yang, J., Retnakaran, R. R., Han, J., Zhang, X., Hao, W., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.010 · Cited by 5
Guglielmi, R., Mian, C., Novizio, R., Paoletta, A., Persichetti, A., Samperi, I., Scoppola, A., Bagnasco, M., Menis, E. D., Rimini, M. L. D., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02652-y · Cited by 6
Thyroid allostasis in drug-free affective disorder patients
Cui, T., Qi, Z., Wang, M., Zhang, X., Wen, W., Gao, S., Zhai, J., Guo, C., Zhang, N., Zhang, R., et al. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.106962 · Cited by 4
Wu, J., Jia, C., Zhang, Z., Hou, Z., & Cui, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303169 · Cited by 4
Bartalena, L., Gallo, D., & Tanda, M. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00071-0 · Cited by 5
Wu, W., McPhaul, M. J., & Wu, Z. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2565-1_43 · Cited by 4
Management of thyroid diseases during pandemic: A narrative review
John, M., & Veetil, V. M. (2020) · Thyroid Research and Practice · doi:10.4103/trp.trp_35_20 · Cited by 4
Wu, W., Yao, S., Liu, D., Luo, Y., Sun, Y., Ruan, T., Liu, M., Shi, L., Liu, C., Xiao, M., et al. (2025) · BMC Immunology · doi:10.1186/s12865-025-00708-5 · Cited by 3
de Almeida, R. J., Hirata, A. H. D. L., Rocha, L. A. D. J., Motta, M. D. D. A., Varela, P., Martins, L. D. O., Pesquero, J. B., & Camacho, C. P. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000625 · Cited by 3
REVIEW OF SARS-CORONAVIRUS-2 REPERCUSSIONS ON THYROID GLAND IN THE CONTEXT OF HYPERTHYROIDISM
Singh, S. V., Monika, Mazumder, R., & Mazumder, A. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.47937 · Cited by 3
Choi, J. H., Hong, Y. O., Kim, H., & Jung, A. R. (2021) · Thyroid Research · doi:10.1186/s13044-021-00115-z · Cited by 3
Phenytoin- Medication That Warrants Deviation From Standard Approach for Thyroid Lab Interpretation
Pattan, V., Candula, N., Adhikari, R., & Kashyap, R. (2020) · Cureus · doi:10.7759/cureus.11324 · Cited by 3
A 6 dimensional approach to diagnosing refractory hypothyroidism
Narayanan, P., Kalra, S., & Monteiro, A. P. D. R. (2020) · Thyroid Research and Practice · doi:10.4103/trp.trp_14_20 · Cited by 2
Polypharmacy as a reason for misinterpreting laboratory results in the elderly
İncir, S., & Bolayirli, M. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.05.001 · Cited by 2
Genetics of Thyroid Function: Relevance for Biology and Disease Management
Sterenborg, R. B. T. M., Peeters, R. P., Visser, W. E., Kuś, A., Smit, J. W. A., Teumer, A., & Medici, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf491 · Cited by 2
Impact of Tirzepatide Therapy on Thyroid Disease: Understanding Risks and Emerging Insights
Laos, E. G. M., Serafica, B., Fontaine-Nicola, A., Zhang, L., Abdelhady, K., Berger, R., Schlottmann, F., Pirzada, A., & Masrur, M. A. (2026) · Clinical Obesity · doi:10.1111/cob.70084 · Cited by 2
Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism
Zielinski, R., Sacco, S. J., Dillon, M., Katsetos, M., & Celi, F. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1847857 · Cited by 2
Thyroid disease and laboratory assessment
Devaraj, S., & Garnett, E. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00003-0 · Cited by 2
Patient Population and Test Utilization for Thyroid Function in Local Clinics and Hospitals in Korea
Choi, R., Lee, S. G., & Lee, E. H. (2022) · Diagnostics · doi:10.3390/diagnostics12071638 · Cited by 2
Park, S., Kim, D. J., Hong, Y. S., Lim, S. H., & Park, J. (2022) · Medicine · doi:10.1097/md.0000000000029359 · Cited by 2
Yamashita, C., Hirai, Y., Nishigaito, T., Mitsumoto, K., Mizumoto, A., Kawakami, M., & Uzu, T. (2024) · Renal Replacement Therapy · doi:10.1186/s41100-024-00537-z · Cited by 2
Donner, J. R., & Topor, L. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-52215-5_25 · Cited by 2
Romani, S., Fresse, A., Parassol, N., Gérard, A. O., Levraut, M., Yamani, S., Obberghen, E. K. V., Pariente, A., Rocher, F., Viard, D., et al. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12755 · Cited by 2
Deligiorgi, M. V., & Trafalis, D. T. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2093714 · Cited by 2
Al‐Salameh, A., Scherman, N., Adda, I., André, J., Zerbib, Y., Maizel, J., Lalau, J., Brochot, É., Andréjak, C., & Desailloud, R. (2022) · Life · doi:10.3390/life12122014 · Cited by 2
Yamauchi, I., Yasoda, A., Hakata, T., Yamashita, T., Hirota, K., Ueda, Y., Fujii, T., Taura, D., Sone, M., & Inagaki, N. (2024) · Thyroid Science · doi:10.1016/j.thscie.2024.100009 · Cited by 2
Abnormal thyroid test results in euthyroid state: An appraisal of the role of drugsPreprint
Krishnamurthy, A., Bhattacharya, S., Lathia, T. B., & Deka, N. (2020) · doi:10.22541/au.159414506.65558424 · Cited by 2
Álvarez-Gamero, J. C., García-Ruiz, V. R., & Paz‐Ibarra, J. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000453 · Cited by 2
Refractory hypothyroidism in children: an overview
Metwalley, K. A., & Farghaly, H. S. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0306 · Cited by 1
Mothilal, B., Patil, B. U., Ghongade, P., Pethe, M., & Yelwatkar, S. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_177_25 · Cited by 1
Wielsøe, M., Long, M., Stratidakis, A. K., Renieri, E., Sarigiannis, D. A., & Bonefeld‐Jørgensen, E. C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1760820 · Cited by 1
Thostrup, A. H., Bentestuen, M., Rasmussen, T. L., Szejniuk, W. M., & Zacho, H. D. (2026) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006444 · Cited by 1
Thyroid storm triggered by immune checkpoint inhibitor therapy
Hagiwara, J., Sekine, M., Sakawaki, E., Sakawaki, S., & Takeyama, Y. (2026) · BMJ Case Reports · doi:10.1136/bcr-2026-272027 · Cited by 1
Li, Z., Wang, T., & Liu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1842060 · Cited by 1
Tormenta tiroidea: a propósito de un caso
Navarro, R. G., & Quirós, C. G. (2020) · Revista Ciencia y Salud Integrando conocimientos · doi:10.34192/cienciaysalud.v4i4.156 · Cited by 1
Severe Thyrotoxicosis and Thyroid Storm
Lechner, M. G., & Angell, T. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00001-6 · Cited by 1
Nakkach, M., Nouir, R., Cherni, I., Somai, M., Daoued, F., Dhaou, B. B., BOUSSEMA, F., Hamzaoui, S., & Ghalila, H. (2023) · Instrumentation Science & Technology · doi:10.1080/10739149.2023.2187820 · Cited by 1
Metadata
- Authors
- Burch, H. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Burch, Henry B.
- ORCID
- Burch, Henry B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-08-22
- Volume
- 381
- Issue
- 8
- Pages
- 749-761
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2969848078
- Cited by
- 164
- References
- 78
- Citations by year
- 2026: 22 · 2025: 20 · 2024: 20 · 2023: 23 · 2022: 25 · 2021: 23 · 2020: 26 · 2019: 3
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- drug-induced thyroid dysfunction, thyroid function tests, drug interactions, adverse drug reactions, thyroid hormones
- MeSH terms
- Pharmaceutical Preparations, Humans, Thyroid Gland, Thyroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
